5‐HT4 receptors are not involved in the control of small intestinal transit in the fasted conscious rat

No abstract is available for this paper.

• Publication year

  1996

• Venue

  Neurogastroenterology and Motility

• Publication date

  1996-03-01

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1111/j.1365-2982.1996.tb00236.xPMID 8697180
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Cisapride

  2012cited by this paper
• Regional distribution and ontogeny of 5-HT4 binding sites in rodent brain.

  1994cited by this paper
• 5-HT1A and 5-HT4 receptors mediate inhibition and facilitation of fast synaptic transmission in enteric neurons.

  1994cited by this paper
• The 5‐HT4 Receptor

  1993cited by this paper
• Granisetron and Ondansetron: Effects on the Ileal Brake Mechanism in the Rat

  1993cited by this paper
• Neuropharmacology of emesis in relation to clinical response.

  1992cited by this paper
• Gastrointestinal motility responses to the S and R enantiomers of zacopride, a 5‐HT4 agonist and 5‐HT3 antagonist

  1992cited by this paper
• Effects of 5-HT4 receptor stimulation on basal and electrically evoked release of acetylcholine from guinea-pig myenteric plexus

  1992cited by this paper
• The effects of S(-) and R(+) sulpiride, metoclopramide, cisapride and domperidone on the small intestine suggest DA2-receptors are involved in the control of small intestinal transit time in rats.

  1992cited by this paper
• A comparison of peripheral and central effects of clonidine on rat intestinal transit.

  1992cited by this paper
• Review article: 5‐hydroxytryptamine agonists and antagonists in the modulation of gastrointestinal motility and sensation: clinical implications

  1992cited by this paper
• Novel enteric 5-HT4 receptors and gastrointestinal prokinetic action.

  1991cited by this paper
• "Prokinetic" treatment of constipation-predominant irritable bowel syndrome: a placebo-controlled study of cisapride.

  1991cited by this paper
• Peristalsis evoked by 5‐HT and renzapride: evidence for putative 5‐HT4 receptor activation

  1991cited by this paper
• Treatment of postoperative paralytic ileus with cisapride.

  1991cited by this paper
• Investigation into the 5‐hydroxytryptamine receptor mediating smooth muscle relaxation in the rat oesophagus

  1991cited by this paper
• Effects of cisapride on gastrointestinal transit in healthy humans

  1990cited by this paper
• Effect of six weeks of treatment with cisapride in gastroparesis and intestinal pseudoobstruction.

  1989cited by this paper
• Effects of cisapride on cholinergic neurotransmission and propulsive motility in the guinea pig ileum.

  1989cited by this paper
• From metoclopramide to selective gut motility stimulants and 5-HT3 receptor antagonists.

  1988cited by this paper
• Effect of metoclopramide, bethanechol and the cholecystokinin receptor antagonist, L-364,718, on gastric emptying in the rat.

  1988cited by this paper
• From metoclopramide to selective gut motility stimulants and 5-HT3 receptor antagonists.

  1988cited by this paper
• Effect of metoclopramide, bethanechol and the cholecystokinin receptor antagonist, L-364,718, on gastric emptying in the rat

  1988cited by this paper
• Development and clinical use of the new gastrointestinal prokinetic drug cisapride (R 51 619)

  1986cited by this paper
• Peripheral neural serotonin receptors: identification and characterization with specific antagonists and agonists.

  1986cited by this paper
• Non‐antidopaminergic, non‐cholinergic stimulation of gastric emptying with cisapride (R 51 619) in rats

  1986cited by this paper
• An analysis of the hypothalamic sites at which substituted benzamide drugs act to facilitate gastric emptying in the guinea-pig.

  1985cited by this paper
• Gastrointestinal Motility

  1985cited by this paper
• Effect of yohimbine on xylazine-induced prolongation of gastrointestinal transit in dogs.

  1983cited by this paper
• Effect of metoclopramide on normal and delayed gastric emptying in gastroesophageal reflux patients

  1983cited by this paper
• Morphine inhibits gastrointestinal transit in the rat primarily by impairing propulsive activity of the small intestine.

  1982cited by this paper
• Gastrointestinal propulsion measurement with radiopaque capsules during 16,16-dimethyl PGE2 infusion.

  1982cited by this paper
• Accurate measurement of intestinal transit in the rat.

  1981cited by this paper
• STUDIES ON SOME para‐SUBSTITUTED CLONIDINE DERIVATIVES THAT EXHIBIT AN α‐ADRENOCEPTOR STIMULANT ACTIVITY

  1980cited by this paper
• Clonidine delays small intestinal transit in the rat.

  1980cited by this paper
• A simplified method for assessing drug effects on gastric emptying in rats.

  1980cited by this paper
• Evidence for noncholinergic mediation of small intestinal transit in the rat.

  1979cited by this paper
• [3H]Para-amino-clonidine: a novel ligand which binds with high affinity to alpha-adrenergic receptors.

  1979cited by this paper
• [3H]Para-amino-clonidine: A novel ligand which binds with high affinity to α-adrenergic receptors

  1979cited by this paper
• Gastrointestinal actions of metoclopramide. An experimental study.

  1967cited by this paper
• Humors, hormones, and neurosecretions; the origins and development of man's present knowledge of the humoral control of body functions.

  1963cited by this paper

• Zebrafish based assays for the assessment of cardiac, visual and gut function--potential safety screens for early drug discovery.

  2008cites this paper
• Endogenous ghrelin and 5-HT regulate interdigestive gastrointestinal contractions in conscious rats.

  2008cites this paper
• Noncardiac Chest Pain: Pathophysiology

  2006cites this paper
• Functional chest pain: nociception and visceral hyperalgesia.

  2005cites this paper
• Serotonin ve Gastrointestinal Sistem

  2003cites this paper
• Serotnin Ve Gastrointestinal Sistem

  2003cites this paper
• Does esophageal function vary at the striated and smooth muscle segments in functional chest pain

  2002cites this paper
• Functional chest pain of esophageal origin: hyperalgesia or motor dysfunction.

  2001cites this paper
• 5-HT3/5-HT4 Receptors in Motility Disorders

  2000cites this paper
• Acceleration of gastrointestinal transit by momordin Ic in mice: possible involvement of 5-hydroxytryptamine, 5-HT(2) receptors and prostaglandins.

  2000cites this paper
• Peptidergic regulation of gastrointestinal motility in rodents.

  2000cites this paper
• Possible involvement of 5-HT and 5-HT2 receptors in acceleration of gastrointestinal transit by escin Ib in mice.

  2000cites this paper
• Increased defecation during stress or after 5‐hydroxytryptophan: selective inhibition by the 5‐HT4 receptor antagonist, SB‐207266

  2000cites this paper
• 5‐HT4 receptor antagonism in irritable bowel syndrome: effect of SB‐207266‐A on rectal sensitivity and small bowel transit

  1999cites this paper
• The pharmacological properties of the novel selective 5‐HT3 receptor antagonist, alosetron, and its effects on normal and perturbed small intestinal transit in the fasted rat

  1999cites this paper
• Clinical Evaluation of Visceral Pain

  1999cites this paper
• Intestinal prokinesia by two esters of 4-amino-5-chloro-2- methoxybenzoic acid: involvement of 5-hydroxytryptamine-4 receptors and dissociation from cardiac effects in vivo.

  1999cites this paper
• SB‐207266: 5‐HT4 receptor antagonism in human isolated gut and prevention of 5‐HT‐evoked sensitization of peristalsis and increased defaecation in animal models

  1998cites this paper
• Functional gut disorders: from motility to sensitivity disorders. A review of current and investigational drugs for their management.

  1998cites this paper
• Pharmacological characterization of the 5‐hydroxytryptamine receptor mediating relaxation in the rat isolated ileum

  1996cites this paper